Ras-mutant Solid Tumors

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-04-13
Clinical Trial Update: Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer [Phase 1]
Phase 1 trial testing the combination of ZEN003694 and Binimetinib in patients with advanced, metastatic, or unresectable solid tumors with …